a highly experienced management team
with a proven track record
in the pharmaceutical industry.
INNOCAN HARNESSES THE WIDE THERAPEUTIC POTENTIAL OF CANNABINOIDS
Quality of life
Improved efficacy, administration and compliance
All out products are to be clinically proven with a Post Marketing Surveillance study.
OUR FIRST-LINE PRODUCTS
INNOVATIVE, FAST-ACTING PAIN RELIEF
1.5 billion people worldwide are affected by pain, with 50% of doctors’ visits pain related!
We at InnoCan want to help the millions of patients seeking better topicaltreatment options for a better quality of life.
Patent-pending, enhanced formula with smart delivery system
Powerful synergistic effect of Menthol & Methyl salicylate with Hemp oil (Cannabinoid complex)
MULTI DISCIPLINARY MANAGEMENT TEAM WITH
Successful Israeli entrepreneur and expert in the establishment and management of start-ups; overseeing operations, business development and product development. Co-founded three stem-cell technology companies: Pluristem (NASDAQ:PSTI), Brainstorm (NASDAQ:BCLI) and Cell Source Ltd (CLCS.OB).
Vast CFO experience for public and private companies. Served as the CFO of Pfizer Israel, Merck-Serono and InterPharm. Extensive experience in Biotech.
Expert in business strategy, process improvement, and supply chain management. Accompanied fast-growing companies from early stage to the highly regulated arena of public companies
Senior pharmaceutics and cosmetics consultant to start-ups and established companies, with more than 30 years of experience. Consults on a wide range of issues including pharmaceutical and cosmetic innovation, generic formulations, and the synthesis of new materials. Serves as VP R&D at Emilia Cosmetics Israel and Emilia Resources in the US. Previously VP R&D at Careline, a member of the pharmaceutical innovation team at Perrigo. He holds several patents.
Served as CEO, President, Chairman of the Board, Executive & non-Executive Board Director at public and private corporations, mainly in the USA. He has been involved with and led M&A transactions worth billions of dollars.
Dr. Stephen Cherkez
Served as head of Teva’s Chemical Research Division; founder of Chem-Agis and President of its chemistry division; and VP BD at Agis. Since 2003, he has held a double position at Perrigo as VP Intellectual Property and VP Product Development. He has filed and participated in the writing of 33 patent families.